ProfileGDS5822 / ILMN_1221918
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 43% 29% 34% 13% 11% 4% 29% 33% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 119.343
GSM1276600PDAC Late Ablation Control 217.129
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 114.434
GSM1276603PDAC Late Ablation 29.813
GSM1276604PDAC Late Ablation 38.711
GSM1303940PDAC Late Ablation_anti-CTLA4 16.44
GSM1303941PDAC Late Ablation_anti-CTLA4 214.329
GSM1303942PDAC Late Ablation_anti-CTLA4 315.933